Please assess the completion status of the following clinical trial:

Trial Title: Study of the Use of Misoprostol to Decrease Bleeding During a Myomectomy

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* patients with symptomatic fibroids who desire future fertility and or who wish to maintain their uterus.~Exclusion Criteria:~* patients who have had previous myomectomy or previous pelvic surgery.~* patients who are severely anemic or who have significant medical conditions such as cardiac or pulmonary disease.~* patients who refuse to participate or give consent to the procedures. Patients with a known allergy to any of the study drugs.

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Misoprostol + vasopressin, Vasopressin (Type: EXPERIMENTAL): Misoprostol 400ug given rectally one hour before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).